The new Microsoft partnership aims to enhance data interoperability with artificial intelligence and machine learning and drive a global transition to precision medicine.
WHY IT MATTERS
Multimodal health data sets can be the largest and most complex to structure, analyze and archive.
The…
Source: Healthcareitnews.com and Read More
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
